| Identification | Back Directory | [Name]
Timelotem | [CAS]
96306-34-2 | [Synonyms]
Timelotem
Timelotemum
Unii-090de9crp1
Timelotemum [latin]
Pyrazino[1,2-a][1,4]benzodiazepine, 10-fluoro-1,2,3,4,4a,5-hexahydro-3-methyl-7-(2-thienyl)-
(+-)-10-Fluoro-1,2,3,4,4A,5-hexahydro-3-methyl-7-(2-thienyl)pyrazino(1,2-A)(1,4)benzodiazepine
Pyrasino(1,2-A)(1,4)benzodiazepine, 10-fluoro-1,2,3,4,4A,5-hexahydro-3-methyl-7-(2-thienyl)-, (+-)- | [Molecular Formula]
C17H18FN3S | [MOL File]
96306-34-2.mol | [Molecular Weight]
315.41 |
| Chemical Properties | Back Directory | [Melting point ]
128-129 °C(Solv: ethanol (64-17-5)) | [Boiling point ]
429.8±45.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [pka]
8.14±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
Timelotem (KC-7507 free base) is a representative of a class of 1, 2-cyclo1, 4-benzodiazepines. Timelotem shows significant antipsychotic properties. Timelotem produces sedative, anti-anxiety and anti-convulsant effects by enhancing the action of the neurotransmitter gamma-aminobutyric acid (GABA). Timelotem can be used in studies of schizophrenia and other mental disorders[1]. | [References]
[1] Gielsdorf W, et al. Determination of timelotem dihydrogenmaleate and its main metabolite N-desmethyltimelotem in plasma by capillary gas chromatography[J]. Journal of Chromatography B: Biomedical Sciences and Applications, 1987, 419: 357-362. DOI:10.1016/0378-4347(87)80300-6 |
|
|